Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$585M Sell
1,648,810
-28,235
-2% -$7.51M 0.07% 249
2026
Q1
$254M Sell
1,677,045
-149
-0% -$18.1K 0.04% 503
2025
Q4
$183M Sell
1,677,194
-385,568
-19% -$56.1M 0.03% 621
2025
Q3
$292M Sell
2,062,762
-1,229,572
-37% -$179M 0.05% 405
2025
Q2
$533M Buy
3,292,334
+437,309
+15% +$54.3M 0.09% 213
2025
Q1
$305M Buy
2,855,025
+956,835
+50% +$133M 0.06% 345
2024
Q4
$234M Buy
1,898,190
+1,121,350
+144% +$158M 0.04% 431
2024
Q3
$111M Buy
776,840
+100,326
+15% +$14.3M 0.02% 674
2024
Q2
$111M Buy
676,514
+553,308
+449% +$68.8M 0.03% 598
2024
Q1
$15.4M Sell
123,206
-9,236
-7% -$979K ﹤0.01% 1905
2023
Q4
$9.95M Buy
132,442
+118,737
+866% +$6.94M ﹤0.01% 2099
2023
Q3
$733K Buy
+13,705
New +$758K ﹤0.01% 4357

Other funds holding ARM

UBS Group's ARM Position: Q2 2026 in Review

UBS Group reduced its Arm (ARM) stake by 1.7% in Q2 2026, selling an estimated $7.51M and leaving 1,648,810 shares worth $585M. The position accounts for 0.07% of the portfolio, ranked #249.

UBS Group first reported a position in ARM in Q3 2023 and has held it in 12 quarters since. 956 funds tracked by Wall St. Rank hold ARM as of Q2 2026.

  • UBS Group held 1,648,810 shares of Arm worth $585M as of Q2 2026.
  • UBS Group sold 28,235 Arm shares in Q2 2026, an estimated $7.51M.
  • Arm made up 0.07% of UBS Group's portfolio in Q2 2026, its #249 holding.
  • UBS Group first reported a position in Arm in Q3 2023 and has held it in 12 quarters since.
  • 956 funds tracked by Wall St. Rank held Arm as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.